Bifunctional peptidylglycine ␣-amidating monooxygenase (PAM) catalyzes the copper-, ascorbate-, and O 2 -dependent cleavage of C-terminal glycine-extended peptides and N-acylglycines to the corresponding amides and glyoxylate. The ␣-amidated peptides and the long-chain acylamides are hormones in humans and other mammals. Bile acid glycine conjugates are also substrates for PAM leading to the formation of bile acid amides. The (V MAX /K m ) app values for the bile acid glycine conjugates are comparable to other known PAM substrates. The highest (V MAX /K m ) app value, 3.1 ؎ 0.12 ؋ 10 5 M ؊1 s ؊1 for 3-sulfolithocholylglycine, is 6.7-fold higher than that for D-Tyr-Val-Gly, a representative peptide substrate. The time course for O 2 consumption and glyoxylate production indicates that bile acid glycine conjugate amidation is a two-step reaction. The bile acid glycine conjugate is first converted to an N-bile acyl-␣-hydroxyglycine intermediate which is ultimately dealkylated to the bile acid amide and glyoxylate. The enzymatically produced bile acid amides and the carbinolamide intermediates were characterized by mass spectrometry and twodimensional 1 H-13 C heteronuclear multiple quantum coherence NMR.
role in the biosynthesis of ␣-amidated peptide hormones (7) (8) (9) and has been proposed to be involved in the biosynthesis of the fatty acid primary amides (10) .
PAM is a bifunctional, copper-and zinc-dependent monooxygenase that catalyzes the oxidative cleavage of C-terminal glycine-extended peptide precursors and N-fatty acylglycines to the corresponding amidated hormones and glyoxylate (for recent reviews, see Refs. 11, 12) . Recently, we have reported that the (V MAX / K m ) app for N-acylglycine amidation increases as the length of the acyl chain increases, reaching a plateau value that is comparable to that obtained with the glycine-extended peptide substrates (13) . For example, the (V MAX /K m ) app for N-decanoylglycine amidation is 3.3-fold higher than the value obtained for D-Tyr-ValGly, a representative peptide substrate. The N-acylglycines are produced enzymatically from the acyl-CoA thioesters and glycine by acyl-CoA:glycine N-acyltransferase (ACGNAT, EC 2.3.1.13) (14, 15) . ACGNAT is found primarily in the liver and kidney, but does colocalize with PAM in the cerebrum and the cerebellum (16, 17) . The discovery that PAM efficiently amidates N-fatty acylglycines (10, 13) suggests that the enzyme may have role in the biosynthesis of fatty acid primary amides in vivo and is a lead for the development of novel therapeutics specifically targeted against PAM. In addition, PAM may also amidate other biologically occurring, nonpeptide substrates leading to the formation of other undiscovered carboxamidated compounds.
One possible class of unrecognized, nonpeptide substrates for PAM that occurs physiologically is the bile acid glycine conjugates. These compounds are made in the liver (20) , a tissue that does not contain PAM activity (17) (18) (19) . However, liver disease can result in a substantial elevation (ϳ50 M) in bile acid glycine conjugates in serum (21, 22) and PAM is found in serum (17, 18) . The circulating bile acid glycine conjugates might also be transported to tissues that contain high levels of PAM like the hypothalamus, the pituitary, or the atrium (17, 18, 23) .
We now report that PAM will amidate the bile acid glycine conjugates to the bile acid amides. These compounds, whose structures diverge considerably from those of the glycine-extended peptides and the N-acylglycines, are excellent substrates with (V MAX /K m ) app values that are two-to sevenfold higher than that measured for D-Tyr-Val-Gly. We further show that N-cholyl-␣-hydroxyglycine is an intermediate in the PAM-catalyzed amidation of cholylglycine to cholanamide.
EXPERIMENTAL PROCEDURES
Materials. Sodium salts of chenodeoxycholylglycine, deoxycholylglycine, 3-sulfolithocholylglycine and cholyltaurine, N-dansyl-TyrVal-Gly, D-Tyr-Val-Gly, sodium ascorbate, rabbit muscle lactate dehydrogenase, glyoxylic acid monohydrate, and NADH were obtained from Sigma Chemical Co. (St. Louis, MO), N-acetylglycine and [ glycyl-1,2-13 C 2 ]cholylglycine was obtained from Aldrich Chemical Co. (Milwaukee, WI), and the sodium salt of cholylglycine was from Fluka Biochemicals (Milwaukee, WI). N-Acetyl-L-phenylalanylpyruvate (N-Ac-Phe-pyruvate, 2,4-diketo-5-acetamido-6-phenylhexanoic acid) was synthesized as described (24) , but with a modified hydrolysis procedure (13) . All other reagents were of the highest quality available commercially.
Initial rate studies. Reactions at 37.0 Ϯ 0.1°C were initiated by the addition of PAM (10 -50 g) into 2.4 ml of 100 mM Mes/NaOH, pH 6.0, 30 mM NaCl, 1% (v/v) ethanol, 0.001% (v/v) Triton X-100, 1.0 M Cu(NO 3 ) 2 , 5.0 mM sodium ascorbate, and the bile acid glycine conjugate (generally 0.2 K m,app to 3.0 K m,app ). Initial rates were measured by following the PAM-dependent consumption of O 2 using a Yellow Springs Instrument Model 53 oxygen monitor. V MAX,app values were normalized to controls performed at 11.0 mM N-acetylglycine. Ethanol was added to protect the catalase against ascorbate-mediated inactivation and Triton X-100 was included to prevent nonspecific absorption of the enzyme to the sides of the oxygen monitor chambers.
Bifunctional peptidylglycine ␣-amidating monooxygenase. Chinese hamster ovary cells that secrete recombinant type A rat medullary thyroid carcinoma PAM into the culture media (25) were grown in a Cellco Cellmax-100 hollow fiber bioreactor (26) . The bifunctional enzyme was purified as described by Miller et al. (27) except that the final gel filtration step (Sephacryl S-300) was done using 20 mM Hepes/NaOH, pH 7.8, 50 mM NaCl, 0.001% (v/v) Triton X-100. The amidation of N-dansyl-Tyr-Val-Gly to N-dansyl-TyrVal-NH 2 (28) was used throughout the enzyme purification to screen column fractions. Unless noted, the PAM used in these studies had a specific activity of Ն3.0 mol of O 2 consumed/min/mg at 37°C under standard conditions. Standard conditions were as follows: 100 mM Mes/NaOH, pH 6.0, 30 mM NaCl, 1% (v/v) ethanol, 0.001% (v/v) Triton X-100, 10 g/ml bovine catalase, 1.0 M Cu(NO 3 ) 2 , 5.0 mM sodium ascorbate, and 11.0 mM N-acetylglycine.
Glyoxylate determination. Glyoxylate was determined by the spectrophotometric method of Christman et al. (29) as modified by Katopodis and May (30) The reaction mixture was incubated at 37°C for 3 h, after which time PAM was removed by ultrafiltration using an Amicon Centricon-30 filter. Experiment B: The reaction was done in a manner analogous to that of experiment A, but no PAM and no N-Ac-Phe-pyruvate were added to provide a control. Experiment C: The reaction was done in a manner analogous to that of experiment A, but no N-Ac-Phepyruvate was added.
An aliquot (0.7 mL) of each of the reaction mixtures (A, B, and C) was taken and analyzed by HMQC NMR using an 
LC-MS.
Aliquots of reaction mixtures were analyzed by reversedphase HPLC, using a 2.1-mm-i.d. ϫ 15-cm Brownlee Aquapore C 8 5-m column. The mobile phase was a linear 30 -100% gradient of acetonitrile in 0.1% (v/v) aqueous formic acid at a flow rate of 0.2 ml/min. The eluent was split 1:1 with 0.1 ml/min passed into the IonSpray interface of a PE-Sciex (Concorde, Ontario, Canada) API III triple quadrupole mass spectrometer. For positive ion spectra, the IonSpray needle voltage and the orifice potential were set at ϩ5400 and 60 -75 V, respectively. The corresponding voltages for negative ion spectra were Ϫ4900 and Ϫ60 to Ϫ70 V. Mass spectra were collected over a m/z range of 300 -600. To collect MS-MS data, parent molecular ions were selected in the first quadrupole, collided with 90% Ar-10% N 2 , and the resulting daughter ions analyzed in the third quadrupole. Data were processed using software provided by the manufacturer.
Data analysis. Kinetic parameters for linear double reciprocal plots were fit to
where K m,app is the apparent Michaelis constant for the bile acid glycine conjugate, A, at constant fixed concentrations of ascorbate and O 2 , and V MAX,app is the apparent catalytic rate at saturating [A] under the conditions of the experiment (31).
RESULTS
Steady-state kinetic studies. Addition of PAM to cholylglycine, deoxycholylglycine, chenodeoxycholylglycine, or 3-sulfolithocholylglycine results in the consumption of O 2 . The initial rate of O 2 consumption increases as the initial concentration of the bile acid glycine conjugate increases. Analysis of the substrate concentration dependence of the initial rates generates the steady-state kinetic parameters summarized in Table I. The highest (V MAX /K m ) app value obtained for the oxidation of a bile acid glycine conjugate was 3-sulfolithocholylglycine, 3.1 Ϯ 0.12 ϫ 10 5 M Ϫ1 s Ϫ1 . This value is 6.7-fold higher than the value obtained for the oxidation of D-Tyr-Val-Gly and is comparable to the best glycine-extended peptide (32) 3 and the N-acylglycine substrates (13) . For example, the ratio of the (
Cholyltaurine is neither a substrate nor an inhibitor for PAM, consistent with substrate specificity studies showing that only glycine-extended and D-alanine-extended peptides are amidated by bifunctional PAM (33) .
Oxidation of the bile acid glycine conjugates. The data in Table I are evidence only for the PAM-dependent oxidation of O 2 in the presence of the bile acid glycine conjugates and ascorbate. Uncoupling of substrate oxidation from ascorbate oxidation by the bile acid glycine conjugates would result in the O 2 consumption with little formation of the bile acid amides and glyoxylate. Conclusive proof for the oxidation of the bile acid glycine conjugates requires the identification of the reaction products (see below). The PAMdependent formation of glyoxylate from the bile acid glycine conjugates provides a convenient, general assay for the cleavage of the C ␣ -N bond in the glycine moiety. Glyoxylate production upon the amidation of the glycine-extended peptides (7, 34) , the N-acylglycines (13), and hippurate (N-benzoylglycine) (30) has been reported. Incubation of the bile acid glycine conjugates with PAM and ascorbate leads to the formation of glyoxylate (Table II) . The PAM-dependent consumption of O 2 shown in Table I Fig. 2 ). In the negative ion mode, the m/z 464
Ϫ cholanamide-acetate adduct molecular ion appeared (data not shown). A similar pattern of results was obtained upon the analysis of the reaction products generated by incubating PAM with deoxycholylglycine and chenodeoxycholylglycine. The m/z values as determined by LC-MS for the products of the reaction of PAM with cholylglycine, deoxycholylglycine, chenodeoxycholylglycine, and 3-sulfolithocholylglycine are summarized in Table III .
Amidation of the bile acid glycine conjugates proceeds via a carbinolamide intermediate.
The amidation of the glycine-extended peptides (35, 36) and the N-acylglycines (13) occurs in two steps. In the first step, O 2 -dependent hydroxylation of the glycyl ␣-carbon forms a carbinolamide (36) . In the second step, O 2 -independent dealkylation of the carbinolamide yields the amide and glyoxylate (37) . Each step is catalyzed by a separate catalytic domain in bifunctional PAM. Peptidyl ␣-hydroxylating monooxygenase (PHM) catalyzes the hydroxylation reaction and peptidylamidoglycolate lyase (PAL) catalyzes the dealkylation re- action. The presence of an alternatively spliced dibasic amino acid processing site between the PHM and PAL domains in bifunctional PAM facilitates the proteolytic separation of PHM and PAL into individual catalytic units (25, 38) . The addition of PAM to 75 M cholylglycine results in the consumption of O 2 and the production of glyoxylate (Fig. 3) . However, the rate of glyoxylate production is ϳ4-fold slower than the rate of O 2 consumption. This result indicates that there must be the initial formation of an oxidized intermediate from cholylglycine which then decays to the glyoxylate. A second reaction done in the presence of 22.5 M N-Ac-Phe-pyruvate, a PAL-specific inhibitor with a K i ϭ 0.24 M (24), shows Ͼ50-fold decrease in the rate of glyoxylate production with almost no effect on the rate of O 2 consumption (Fig. 3) is the carbinolamide, N-cholyl-␣-hydroxyglycine. Incubations of PAM with deoxycholylglycine and chenodeoxycholylglycine done in the presence of the PAL-specific inhibitor also show evidence for the formation of the carbinolamide intermediate (Table III) .
DISCUSSION

Bile acid glycine conjugates as PAM substrates.
PAM preferentially amidates C-terminal glycine-extended peptides with a penultimate hydrophobic amino acid (32) . In addition, Erion et al. (40) have shown that the affinity of PAM for C-terminal homocysteine-extended peptide inhibitors increases when the penultimate residue is a hydrophobic amino acid. The bile acid glycine conjugates possess a hydrophobic steroid moiety adjacent to the glycyl residue and prove to be excellent substrates for PAM. The (V MAX /K m ) app values for all the bile acid glycine conjugates tested in this study are greater than the (V MAX /K m ) app value measured for a representative peptide substrate, D-Tyr-Val-Gly, and compare favorably with (V MAX /K m ) app values measured for the best long-chain N-acylglycine (13) and C-terminal glycine-extended peptide substrates (32) ( Table I) . 3 PHM is a prolate ellipsoid composed of two separate domains that form a highly hydrophobic pocket (41) . It may be that the steroid moiety of the bile acid glycine conjugates intercalates between these domains and thereby positions the glycyl moiety in the active site. The approximately threefold variation in the (V MAX / K m ) app for the bile acid glycine conjugates may result from differences in their binding to PHM as consequence of the decoration of the steroid moiety with a differing ensemble of hydroxyl or sulfate functionalities. The cocrystallization of PAM with a bile acid glycine conjugate would provide considerable information concerning the interactions of the enzyme with this class of nonpeptide substrates.
Characterization of the enzymatically generated reaction products. The kinetic constants shown in Table I were generated by measuring the PAM-dependent consumption of O 2 in the presence of the bile acid glycine conjugate and ascorbate. These data are not proof of the oxidative modification/cleavage of the bile acid glycine conjugate, but instead could represent the Note. Reactions were initiated by the addition of 17 g of PAM into 1.2 ml of 100 mM Mes/NaOH, pH 6.0, 30 mM NaCl, 1.0% (v/v) ethanol, 0.001% (v/v) Triton X-100, 5.0 mM sodium ascorbate, 1.0 M Cu(NO 3 ) 2 , 10 g/ml catalase, and 150 M bile acid glycine conjugate. After 3 h at 37°C, reactions were terminated by the addition of 200 l of 6% (v/v) trifluoroacetic acid and glyoxylate was determined spectrophotometrically (see Experimental Procedures). No glyoxylate was formed in controls lacking the glycine conjugate or PAM. Error bars represent the standard deviation of duplicate reactions. Oxidative cleavage of the glycyl moiety of any bile acid glycine conjugates, as catalyzed by bifunctional PAM, would lead to the production of glyoxylate (7, 13, 30) . Glyoxylate is formed upon the incubation of four different bile acid glycine conjugates with PAM (Table II) , indicative of C ␣ -N bond scission in the glycyl moiety. Further analysis of the reaction mixtures by LC-MS shows that PAM converts the bile acid glycine conjugates to the corresponding bile acid amides (Table III) .
FIG. 1. LC-ESI-MS
The PAM-mediated amidation of glycine-extended peptides (24, 36) , N-acylglycines (13) , and N-arylglycines (42) proceeds through an ␣-hydroxyglycine, carbinolamide intermediate. The carbinolamide is subsequently dealkylated to the amide and glyoxylate. The individual catalytic domains of bifunctional PAM (or monofunctional PHM and PAL) catalyze the two steps of the amidation reaction. The addition of PAM to cholylglycine results in the consumption of O 2 at a rate that is approximately fourfold higher than the rate of
FIG. 2.
Tandem mass spectrometry of the cholanamide m/z 408 peak in Fig. 1 . The reaction mixture following incubation of cholylglycine with PAM was analyzed by reversed-phase HPLC and ESI-MS as described in Fig. 1 . The IonSpray needle voltage was 5500 V and the orifice potential ϩ75 V. Ions (m/z 408) were selected in the first quadrupole filter and then allowed to collide with argon-10% nitrogen gas. Fragment ions were analyzed in the third quadrupole to obtain the daughter ion mass spectrum. 
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THE AMIDATION OF BILE ACID GLYCINE CONJUGATES glyoxylate production (Fig. 3) . The best explanation for this result is that an oxidized intermediate must first form from cholylglycine before the production of cholanamide and glyoxylate. By analogy to the earlier studies, the intermediate is likely to be N-cholyl-␣-hydroxyglycine.
The hydroxylation/dealkylation of [glycyl-1,2-13 C 2 ]-cholylglycine was followed by 1 (Fig. 4) .
LC-MS of a similar reaction done using unlabeled cholylglycine is also consistent with the formation of N-cholyl-␣-hydroxyglycine (Fig. 5 and Table III ). The PAM-catalyzed amidation of the cholylglycine conjugates is, thus, completely analogous to the glycine-extended peptide and N-acylglycine reactions. The initial formation N-cholyl-␣-hydroxyglycine is followed by dealkylation to cholanamide and glyoxylate (Scheme I).
The biosynthesis of bile acid amides. Bile acid-CoA: amino acid N-acyltransferase (BAT, EC 2.3.1.65) catalyzes the transfer of the bile acid moiety from bile acid-CoA to either glycine (H 2 N-CH 2 -COOH) and taurine (H 2 N-CH 2 -CH 2 -SO 3 H) to form the respective bile acid amidate. The sequential actions of BAT and PAM would convert the bile acid-CoA thioesters and glycine to the respective bile acid amides and glyoxylate (Scheme II).
Tissue distribution studies indicate that BAT is found only in the liver and kidney of mammals (43) . The tissue distribution of mammalian PAM is widespread, with the highest concentrations being found in the hypothalamus, the pituitary, and the atria of the heart (17, 18, 23) . Detectable levels of PAM are also found in the plasma (17, 18) , the cerebrospinal fluid (44, 45) , and throughout the central nervous system (17, 46 -48) . The liver and the kidney are virtually devoid of PAM (17) (18) (19) . As a consequence, the biosynthesis of the bile acid amides is not likely to occur in the liver and the kidney. Instead, we propose that the bile acid glycine conjugates are first made in the liver and are then transported to tissue(s) containing PAM for subsequent amidation.
Two attractive sites for the PAM-catalyzed amidation of the bile acid glycine conjugates are the blood and the choroid plexus. The bile acid glycine conjugates are known to accumulate in both the blood (in cholestatic liver disease) (21, 22) and in the choroid plexus (49) and PAM has been identified in both (17, 18, 48) .
FIG. 3.
The PAM-catalyzed consumption of O 2 (-) and the production of glyoxylate (F) from cholylglycine. Reactions at 37°C were initiated by the addition of PAM (74 g) to 4.0 ml of 100 mM Mes/NaOH, pH 6.0, 30 mM NaCl, 1.0% (v/v) ethanol, 0.001% (v/v) Triton X-100, 10 g/ml catalase, 1.0 M Cu(NO 3 ) 2 , 5.0 mM sodium ascorbate, and 75 M cholylglycine. Progress curves for the consumption of O 2 (---) and the production of glyoxylate (E) from 75 M cholylglycine and 22.5 M N-Ac-Phe-pyruvate are also included. In one sample, O 2 consumption was measured using an O 2 electrode. In a matched second sample, aliquots were removed at the indicated time and added to a vial containing one-fifth volume of 6% (v/v) trifluoroacetic acid to quench the reaction. The concentration of glyoxylate in each quenched sample was determined spectrophotometrically (29, 30) . M N-Ac-Phe-pyruvate, and either 0 (A) or 150 g/ml PAM were incubated at 37°C for 3 h. PAM and catalase were removed prior to NMR analysis from both solutions using a Centricon-30 diafilter (Amicon). The NMR spectra were acquired at 600 MHz at 27°C and referenced to acetone as an external standard. Stock solutions of Mes, NaCl, sodium ascorbate, and Cu(NO 3 ) 2 were prepared in D 2 O. Peaks at ca. 63 and 83 ppm on the carbon axis are due to buffer components.
THE AMIDATION OF BILE ACID GLYCINE CONJUGATES
cross the blood-brain barrier. However, receptor-mediated transport may not be required for the bile acid glycine conjugates to cross the blood-brain barrier. These molecules most likely have the dual criteria of sufficient lipid solubility and low molecular weight (Ͻ500 Da) for the unassisted, lipid-mediated movement from the blood into the brain (53) .
Liver dysfunction often results in elevated concentrations of the bile acid glycine conjugates in the blood (21, 22) . If bile acid glycine conjugates are able to cross the blood-brain barrier, increased concentration of these nonpeptide PAM substrates may also inhibit the normal production of the ␣-amidated neuropeptide hormones. Decreased production of neuropeptides may be at least partially responsible for the encephalopathy associated with liver disease (54, 55) .
In conclusion, we have shown that bifunctional peptidylglycine ␣-amidating monooxygenase catalyzes the two-step conversion of the bile acid glycine conjugates to the bile acid amides and glyoxylate via a carbinolamide intermediate. The bile acid amides have never been isolated from a biological system (for a review of bile acid metabolism, see Ref. 56 ) but, if so, may represent a previously unrecognized class of cell signaling molecules.
